Novavax Vaccine 96% Effective Against Original Coronavirus, Late-Stage Trial Confirms
Novavax Inc’s COVID-19 vaccine was 96% effective in preventing cases caused by the original version of the coronavirus. This has been confirmed by a late-stage trial conducted in the United…
Share